Study identity card

POSTCOVID

Poland
Share
  • Disease: Post-COVID-19
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional
  • Study aim: To determine the usefulness of pregabalin in treatment of the post-COVID chronic fatigue syndrome
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from to
  • Study includes follow-up for 6 months

Study Data

  • Adults
  • Elderly
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Pregabalin

Other information

Funders:

  • National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to